Cargando…
NHD2-15, a novel antagonist of Growth Factor Receptor-Bound Protein-2 (GRB2), inhibits leukemic proliferation
The majority of chronic myeloid leukemia (CML) cases are caused by a chromosomal translocation linking the breakpoint cluster region (BCR) gene to the Abelson murine leukemia viral oncogene-1 (ABL1), creating the mutant fusion protein BCR-ABL1. Downstream of BCR-ABL1 is growth factor receptor-bound...
Autores principales: | Lewis, Tina R., Smith, Jesse, Griffin, Kallie, Aguiar, Stephanie, Rueb, Kristen F., Holmberg-Douglas, Natalie, Sampson, Ellen M., Tomasetti, Skylar, Rodriguez, Sofia, Stachura, David L., Arpin, Carolynn C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7418987/ https://www.ncbi.nlm.nih.gov/pubmed/32780746 http://dx.doi.org/10.1371/journal.pone.0236839 |
Ejemplares similares
-
Synergistic anti-leukemic activity of imatinib in combination with a small molecule Grb2 SH2 domain binding antagonist
por: Zhang, Manchao, et al.
Publicado: (2013) -
Attenuated Acceleration to Leukemia after Ezh2 Loss in Nup98-HoxD13 (NHD13) Myelodysplastic Syndrome
por: Ling, Victoria Y., et al.
Publicado: (2019) -
A new hypothesis: imatinib affects leukemic stem cells in the same way it affects all other leukemic cells
por: Tomasetti, C
Publicado: (2011) -
Development of Grb2 SH2 Domain Signaling Antagonists: A Potential New Class of Antiproliferative Agents
por: Burke , Terrence R.
Publicado: (2006) -
Metabolism and biochemical properties of nicotinamide adenine dinucleotide (NAD) analogs, nicotinamide guanine dinucleotide (NGD) and nicotinamide hypoxanthine dinucleotide (NHD)
por: Yaku, Keisuke, et al.
Publicado: (2019)